ABSTRACT. Prognostic factors associated with survival in dogs with lymphocytic-plasmacytic enteritis (LPE) were investigated through a retrospective study. Using case records, 48 dogs diagnosed with LPE were classified as survivors (n=32) or non-survivors (n=16), and the clinical and clinicopathological parameters were reviewed between the 2 groups by using univariate and multivariate prognostic analysis. Compared to the hospital population, non-survivors had an overrepresentation of the Shiba breed. Results of univariate analysis indicated that anorexia, severe weight loss, packed cell volume, and total protein were significantly associated with survival for 6 months after diagnosis. In multivariate analysis, anorexia and hypoproteinemia were significantly associated with survival. Furthermore, initial response to treatment was strongly associated with poor prognosis. Based on these clinical and laboratory parameters such as anorexia, hypoproteinemia and initial response to treatment, it may be possible to predict poor prognosis in canine LPE. KEY WORDS: inflammatory bowel disease (IBD), lymphocytic-plasmacytic enteritis (LPE), prognostic factors.
Lymphocytic-plasmacytic enteritis (LPE) is characterized by the diffuse infiltration of lymphocytes and plasma cells in the enteric lamina propria and is frequently diagnosed in canine inflammatory bowel disease (IBD) [4, 5] . Chronic diarrhea and vomiting are the common symptoms of canine LPE, and protein-losing enteropathy is often observed in severe cases. The cause of LPE is presently unclear, but several etiological factors such as immunological abnormalities, specific enterobacteria, and damage to the mucosal barrier have been proposed [4, 5] . The diagnosis is made on an exclusion basis in that no other etiological factor is found.
The treatment of canine LPE consists of modification of diet or administration of antibiotics such as metronidazole for mild cases, but severe cases often require corticosteroids at immunosuppressive doses. Most cases respond to these treatments, and symptomatic control is possible [7, 8] . However, mortality occurs in some cases due to poor response to treatment. Craven et al. reported that only 26% IBD dogs were in remission at follow-up examination, and 13% dogs were euthanized due to refractory IBD [3] . Therefore, at the time of diagnosis, it would be helpful to recognize the dogs that carry a high risk of poor prognosis. Although eosinophilic enteritis is recognized to carry a worse prognosis than other types of IBD [6] , little is known about the prognostic factors associated with survival in canine LPE.
In the present study, we classified 48 dogs diagnosed with LPE into 2 groups, i.e., survivors or non-survivors, and compared their clinical and laboratory parameters to identify the prognostic factors for canine LPE.
MATERIALS AND METHODS

Criteria for selection of cases:
We reviewed the medical records of 48 dogs diagnosed with LPE at the Veterinary Medical Center of the University of Tokyo (VMC-UT) between April 2001 and March 2005. The inclusional criteria for LPE included persistent gastrointestinal symptoms such as diarrhea or vomiting, failure to identify other causes of gastroenteritis by thorough examination, failure to respond to dietary or antibiotic therapy, and findings of lymphocytic-plasmacytic inflammation on histopathological examination of endoscopically obtained intestinal specimens. The minimal diagnostic examination to exclude other diseases included complete blood count (CBC), serum biochemistry, examination of feces, X-ray examination, and abdominal ultrasonography. Cases were excluded if an underlying or concurrent disorder besides LPE was confirmed or a follow-up of more than 6 months was not possible. All LPE dogs had received suitable treatment depending on the severity of disease and were classified as survivors (n=32) or non-survivors (n=16) at 6 months after the initial diagnosis. All dogs received prednisolone (0.5-1 mg/kg/day, PO, b.i.d.) as an initial treatment. The other treatment included modification of diet (low-residue diet or hypoallergic diet), medications such as metronidazole (10 mg/kg, PO, b.i.d.), azathioprine (2 mg/kg/day), cyclosporine (5-10 mg/kg/day), and sulfasalazine (20 mg/kg, PO, b.i.d.).
Data analysis: Signalment, clinical signs and symptoms, laboratory findings, and response to treatment were compared between survivors and non-survivors. Signalment for comparison included breed, age, and sex differences. Breed incidence in survivors and non-survivors was compared with that of the overall hospital population of VMC-UT dur-ing the same period (from April 2001 to March 2005). The clinical signs and symptoms used for comparison included vomiting, diarrhea, pleural effusion, ascites, depression, anorexia, and degree of weight loss (<30% vs. ≥30%).
The laboratory findings used for comparison included packed cell volume (PCV), white blood cell (WBC) count, platelet (PLT) count, serum biochemistry profile of C-reactive protein (CRP), total protein (TP), albumin (Alb), blood urea nitrogen (BUN), creatinine (Cre), alanine aminotransferase (ALT), total cholesterol (T. Chol), electrolytes [sodium (Na), potassium (K), and chloride (Cl)], calcium (Ca), ammonia (NH 3 ), and lactate dehydrogenase (LDH).
Histopathological severity was classified into 3 (1: mild, 2: moderate, and 3: severe) grades based on the infiltration of lymphocytes/plasma cells and structural changes in the intestinal mucosa as described previously [9] . Regarding the response to treatment, the dogs were classified as responders or non-responders based on the observation of apparent symptomatic (diarrhea, vomiting, and ascites) improvement within 2 weeks of starting the initial treatment. A dog with complete remission or apparent improvement of clinical signs and symptoms was classified as a responder, whereas a dog without apparent improvement or with deterioration of symptoms was classified as a nonresponder.
Statistical analysis: Categorical data are presented as percentages or ratios. Continuous data were examined for normality by the Kolmogorov-Smirnov test and presented as mean ± standard deviation (SD). Fisher's exact test and chisquare test (with Yates' correction where applicable) were used to compare categorical data. Continuous data were compared by Student's t test in the case of equal variance. The Welch test was used to compare continuous data with unequal variance. The log-rank test was used to compare the survival time. The parameters found to be significant on univariate analysis were entered into a multiple logistic regression model. A P value < 0.05 was considered statistically significant. Calculations were performed with statistical software (JMP4.0, SAS institute Inc., Cary, NC).
RESULTS
Signalment:
Forty-eight dogs were included in the study; 32 dogs survived more than 6 months after diagnosis (survivors), and 16 dogs died within 6 months (non-survivors). In the present study, the survival rate was 66.7%. During the period from April 2001 to March 2005, a total of 3,477 dogs were referred to VMC-UT; this translates into an idiopathic LPE incidence of 1.38%.
The gender distribution was 62.5% males and 37.5% females in survivors, whereas it was 75% males and 25% females in non-survivors; no significant difference in gender distribution was observed between the 2 groups. The mean age at admission was 7.3 ± 3.2 yeas in non-survivors and 6.6 ± 3.4 years in survivors; no significant difference was observed between the 2 groups.
The non-survivors included dogs of breeds such as Shiba (6), Maltese (2), miniature Dachshund (2), mixed breed (1), Cavalier King Charles spaniel (1), Golden Retriever (1), pug (1), American Cocker Spaniel (1), and Border Collie (1). Compared to the hospital population, non-survivors had an overrepresentation of Shiba (odds ratio: 14.52, P<0.001; Table 1 ). In addition, compared to the hospital population, LPE dogs had an overrepresentation of breeds such as Shiba (n=9, odds ratio: 5.58, P<0.001) and Maltese (n=7, odds ratio:3.63, P<0.01).
Clinical signs and symptoms: No significant differences were observed between survivors and non-survivors with regard to the presence of diarrhea, vomiting, pleural effusion/ascites, and lethargy. Pleural effusion was present only in 2 dogs among non-survivors. Significant differences were identified between survivors and non-survivors with regard to the presence of anorexia (P<0.01) and severe (≥30%) weight loss (P<0.05); the incidence of both was higher among non-survivors (Table 2) .
Laboratory findings: The mean value of PCV was significantly (P<0.01) decreased in non-survivors (35.0% ± 9.6%) when compared with that in survivors (42.5% ± 8.6%) ( Table 2) . Anemia was observed in 6 dogs (56.3%) among non-survivors and 9 dogs (18.8%) among survivors. Significant differences were not observed in the WBC and PLT counts.
The serum biochemistry parameters in which a significant difference was observed between survivors and nonsurvivors were TP and Cl concentration ( Table 2 ). The mean value of TP in non-survivors was 4.5 ± 1.7 g/dl, whereas it was 3.7 ± 0.9 g/dl in survivors (P<0.05). The TP value was below the reference range (5.4 ± 7.7 g/dl) in 15 Table 2 ).
Multivariate analysis: Multiple logistic regression analysis was carried out to assess the parameters associated independently with outcomes of LPE dogs. For multiple logistic regression analysis, continuous variables were converted to categorical variables by using reference ranges of our laboratory. Of the clinicopathological variables found significant on univariate analysis, presence of anorexia (P=0.002, odds ratio=25.96) and hypoproteinemia (P=0.03, odds ratio=26.1) were found to be significant on multivariate analysis (Table 3) .
Response to therapy: Response to initial treatment was observed in 28 dogs (87.5%) among survivors, but only 2 dogs among non-survivors were responders. The number of non-responders was 14 (87.5%) in non-survivors and 4 (12.5%) in survivors. A significant difference in the response to therapy was observed between survivors and non-survivors (P<0.001; Fig. 1 ). 
Survival analysis:
The log-rank test was performed to assess the effects of parameters that were found to be significant in univariate analysis on the survival period. Breed (Shiba or other breeds), presence of anorexia, severe weight loss, anemia, and hypoproteinemia had no effect on the survival period (data not shown) in non-survivors.
DISCUSSION
In the present study, significant differences were observed in clinical signs and symptoms (anorexia and severe weight loss) and laboratory parameters (PCV and TP) between survivors and non-survivors, indicating that these parameters could be used as prognostic factors for LPE.
Since appetite is usually maintained in LPE dogs (IBD), anorexic dogs should be considered as having poor prognosis. There was a significant decrease in body weight in nonsurvivors, which was probably due to anorexia and the severity of symptoms (diarrhea and vomiting).
In our study, Shiba dogs were overrepresented in non-survivors and appear to be at a higher risk of poor prognosis. Although breed predisposition for LPE has not been fully investigated, some breeds such as Basenjis [10] , Shar-Peis [5] , and German Shepherds [7, 8] have been considered to be at increased risk of LPE. However, the breed predisposition for poor outcome of canine LPE has not been reported. Shiba dogs are commonly affected by atopic dermatitis in Japan [11] , and allergic reactions to food items or intestinal bacteria might be involved in LPE in Shiba dogs. Further studies with a large number of cases are required to clarify the breed predisposition for the prognosis of canine LPE.
CBC and biochemical findings revealed significant decreases in PCV and TP in non-survivors. This is probably due to the loss of blood, protein, and electrolytes from the gastrointestinal tract in dogs with severe LPE. Craven et al. [3] demonstrated that hypoalbuminemia at the time of diagnosis was significantly associated with a negative outcome in IBD dogs. However, no significant differences were identified in the albumin concentration between survivors and non-survivors. The cause of anemia may also include dyshematopoiesis due to chronic inflammation and malnutrition as well as gastrointestinal hemorrhage. In addition, coagulation and anticoagulant factors should be assessed for their association with prognosis in LPE dogs. It has been reported that the histological severity does not correlate with clinical signs and symptoms and treatment outcomes [3, 9] . Similar findings were observed in our study. However, in the present study, the histological examination was performed by several pathologists, indicating the possibility of individual variation in histological grading. Jergen et al. claimed that a clinical score [canine IBD activity index (CIBDAI)] and CRP could reflect the disease severity in IBD dogs [9] . In the present study, no significant difference was recognized in the CRP concentration between the 2 groups, and CIBDAI data could not be obtained due to the retrospective study design. Since the CIBDAI scoring system contains several subjective factors, more objective clinicopathological parameters are suitable as the prognostic factors for LPE.
Apart from clinical and clinicopathological parameters, the initial response to treatment was identified to be another prognostic factor for LPE. Among non-survivors, most dogs did not respond to immunosuppressive doses of corticosteroids and showed no symptomatic improvement within 2 weeks of starting the treatment. On the other hand, most surviving dogs responded to the treatment that included corticosteroids and/or metronidazole even in the presence of anorexia and severe weight loss at the time of diagnosis. Although other immunosuppressive drugs (azathioprine and cyclosporine) or sulfasalazine were also administered to some dogs among non-survivors, none of them responded to these drugs.
Allenspach et al. [1] reported that the expression level of P-glycoprotein (P-gp), one of the drug efflux pumps, in the intestinal mucosa was associated with the response to corticosteroid therapy in IBD dogs. The expression of P-gp may be enhanced in non-survivors at the time of diagnosis. In addition, it is sometimes difficult to differentiate small lymphocytic lymphoma from severe LPE by histological examination of endoscopically obtained biopsy specimens [2] . Therefore, the possibility remains that dogs with small lymphocytic lymphoma were present among non-survivors in the present study. It is important to identify not only prognostic factors for LPE but also diagnostic markers for the discrimination of lymphoma.
In conclusion, the present study indicates that anorexia, hypoproteinemia, and response to initial treatment could be used as prognostic factors for canine LPE. Further investigations are necessary to confirm the clinical usefulness of these parameters through prospective studies and to find new prognostic and diagnostic markers for canine LPE.
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